Brian Lannutti,Wayne Rothbaum,Tjeerd Barf,Allard Kaptein
申请号：
US15297998
公开号：
US20170035881A1
申请日:
2016.10.19
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Therapeutic combinations of an interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor and a Bruton's tyrosine kinase (BTK) inhibitor are described. In some embodiments, the invention provides pharmaceutical compositions comprising combinations of an IRAK4 inhibitor and a BTK inhibitor, and methods of using the pharmaceutical compositions for treating a disease, in particular a cancer.
